Etoposide upregulates Bax-enhancing tumour necrosis factor-related apoptosis inducing ligand-mediated apoptosis in the human hepatocellular carcinoma cell line QGY-7703.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Biochemistry

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.1432-1033.2003.03639.XPMID 12823542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BID regulation by p53 contributes to chemosensitivity

  2002cited by this paper
• The Course of Etoposide-induced Apoptosis from Damage to DNA and p53 Activation to Mitochondrial Release of Cytochromec *

  2002cited by this paper
• TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

  2002cited by this paper
• Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax

  2002cited by this paper
• Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells

  2002cited by this paper
• Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis

  2002cited by this paper
• Apoptosis‐associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl‐2

  2001cited by this paper
• Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.

  2001cited by this paper
• TAXOL INDUCED BCL‐2 PROTEIN PHOSPHORYLATION IN HUMAN HEPATOCELLULAR CARCINOMA QGY‐7703 CELL LINE

  2001cited by this paper
• Diablo Promotes Apoptosis by Removing Miha/Xiap from Processed Caspase 9

  2001cited by this paper
• Evidence that the death receptor DR4 is a DNA damage‐inducible, p53‐regulated gene

  2001cited by this paper
• A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins

  2001cited by this paper
• Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines.

  2001cited by this paper
• p53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon-gamma.

  2001cited by this paper
• Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.

  2000cited by this paper
• Increased Expression of Death Receptors 4 and 5 Synergizes the Apoptosis Response to Combined Treatment with Etoposide and TRAIL

  2000cited by this paper
• The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.

  2000cited by this paper
• New insights into p53 regulation and gene therapy for cancer.

  2000cited by this paper
• Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells.

  2000cited by this paper
• Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

  2000cited by this paper
• Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.

  2000cited by this paper
• Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c

  2000cited by this paper
• Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

  2000cited by this paper
• Role of p53 family members in apoptosis

  2000cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• Induction of apoptosis by cancer chemotherapy.

  2000cited by this paper
• Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

  1999cited by this paper
• Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

  1999cited by this paper
• Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.

  1999cited by this paper
• Safety and antitumor activity of recombinant soluble Apo2 ligand.

  1999cited by this paper
• The TRAIL to selective tumor death

  1999cited by this paper
• Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis*

  1999cited by this paper
• The p53 pathway and apoptosis

  1999cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• APO2 ligand: a novel lethal weapon against malignant glioma?

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

  1997cited by this paper
• Characterization of two receptors for TRAIL.

  1997cited by this paper
• Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

  1997cited by this paper
• The Receptor for the Cytotoxic Ligand TRAIL

  1997cited by this paper
• TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.

  1997cited by this paper
• An antagonist decoy receptor and a death domain-containing receptor for TRAIL.

  1997cited by this paper
• KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene

  1997cited by this paper
• Characterization of two receptors for TRAIL 1

  1997cited by this paper
• A novel receptor for Apo2L/TRAIL contains a truncated death domain.

  1997cited by this paper
• TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

  1997cited by this paper
• Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family*

  1996cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• A novel form of Epstein-Barr virus latency in normal B cells in vivo.

  1995cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• A method for testing for synergy with any number of agents.

  1978cited by this paper
• Changes of Level at Pozzuoli, referred to in the “Apocryphal Acts of Peter and Paul”

  1870cited by this paper

• The Antitumor Effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer

  2020cites this paper
• The Morphology and Proteomics Variance Analysis of QSG-7701 and QGY-7703 Cell Lines after Cisplatin Treatment

  2019cites this paper
• HSV-1 ICP27 induces apoptosis by promoting Bax translocation to mitochondria through interacting with 14-3-3θ

  2017cites this paper
• Discovery and Development of Topoisomerase Inhibitors as Anticancer Agents.

  2016cites this paper
• The role and mechanism of action of BRK in breast cancer progression

  2015cites this paper
• HOOKING TRAIL-R2 TO ¿EDUCATE¿ IMMUNE SYSTEM TO RECOGNIZE CANCER CELLS

  2015cites this paper
• BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration

  2014cites this paper
• Apoptosis-related BCL2-family members: Key players in chemotherapy.

  2014cites this paper
• Hepatocellular carcinoma: targeting of oncogenic signaling networks in TRAIL resistant cancer cells

  2014cites this paper
• Transcriptional Regulation of the Human Tumor Suppressor DOK1 by E2F1

  2012cites this paper
• A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase

  2012cites this paper
• Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody

  2011cites this paper
• Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study.

  2009cites this paper
• Targeting of Apoptosis Signaling Pathways and Their Mediators for Cancer Therapy

  2009cites this paper
• Trail receptors: targets for cancer therapy.

  2008cites this paper
• The Molecular Pathogenesis of Haemangioma

  2008cites this paper
• opoisomerase II inhibitors

  2008cites this paper
• Expression of apoptotic nuclei by ultrastructural terminal deoxyribonucleotidyl transferase mediated dUTP nick end labeling and detection of FasL, caspases and PARP protein molecules in cadmium induced acute alveolar cell injury.

  2006cites this paper
• Topoisomerase II inhibitors.

  2006cites this paper
• Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells.

  2006cites this paper
• Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells

  2006cites this paper
• Topoisomerase II inhibitors.

  2005cites this paper
• RIP3 β and RIP3 γ, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis

  2005cites this paper
• Current status of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) targeting cancer therapy

  2005cites this paper
• Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents.

  2005cites this paper
• RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis.

  2005cites this paper
• Expression Profiling of Human Hepatoma Cells Reveals Global Repression of Genes Involved in Cell Proliferation, Growth, and Apoptosis upon Infection with Parvovirus H-1

  2005cites this paper
• Redox Regulation of Apoptosis by Members of the TNF Superfamily

  2005cites this paper
• Targeting death receptors in cancer with Apo2L/TRAIL.

  2004cites this paper